Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled to have a specific major surgery called a pancreaticoduodenectomy (a surgical procedure to remove part of the pancreas and surrounding structures) to treat cancer
- People who are able to understand and sign a consent form agreeing to take part in the study
Who may not be able to join:
- People who are considered too unwell due to serious health conditions to safely undergo surgery
- People whose cancer cannot be removed by surgery, either based on pre-surgical scans or as determined during a surgical procedure to assess the tumour
- People who have cancer that has spread to other parts of the body (distant metastasis)
- People who choose not to participate in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Saleh K Saleh, MD, Minia University
Phone: 01201765401
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the rate of Postoperative pancreatic fistula within 2 weeks after operation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.